Alterations in the Inotropic Responses to Forskolin and Ca<SUP>2+</SUP> and Reduced Gene Expressions of Ca<SUP>2+</SUP>-Signaling Proteins Induced by Chronic Volume Overload in Rabbits

1. Fowler MB, Laser JA, Hopkins GL, Miobe W, Bristow MR: Assessment of the beta-adrenergic receptor pathway in the intact failing human heart: Progressive receptor down-regulation and subsensitivity to agonist response. Circulation 1986; 74: 1290-1302

2. Kiuchi K, Shannon RP, Komamura K, Cohen DJ, Bianchi C, Homcy CJ, et al: Myocardial beta-adrenergic receptor function during the development of pacing-induced heart failure. J Clin Invest 1993; 91: 907-914

3. Vatner DE, Homcy CJ, Sit SP, Manders WT, Vatner SF: Effects of pressure overload, left ventricular hypertrophy on beta-adrenergic receptors, and responsiveness to catecholamines. J Clin Invest 1984; 73: 1473-1482

10.1016/0022-2828(89)90614-7

5. Beuckelmann DJ, Nabauer M, Erdmann E: Intracellular calcium signaling in isolated ventricular myocytes from patients with terminal heart failure. Circulation 1992; 85: 1046-1055

6. Morgan JP: Abnormal intracellular modulation of calcium as a major cause of cardiac contractile dysfunction. N Engl J Med 1991; 325: 625-632

10.1016/S1071-9164(96)80010-8

ABE S, 1995, 10, 138, 10.1007/BF01744480

9. Bristow MR, Ginsburg R, Strosberg A, Montgomery W, Minobe W: Pharmacology and inotropic potential of forskolin in the human heart. J Clin Invest 1984; 74: 212-223

10.1038/340230a0

Maclennan DH, Brandl CJ, Korczak B,, 1985, 316, 696, 10.1038/316696a0

10.1016/0014-5793(88)81412-1

1994, 269, 5145, 10.1016/S0021-9258(17)37667-6

10.1016/0378-1119(91)90621-H

15. Brillantes AM, Allen P, Takahashi T, Izumo S, Marks AR: Differences in cardiac calcium release channel (ryanodine receptor) expression in myocardium from patients with end-stage heart failure caused by ischemic versus dilated cardiomyopathy. Circ Res 1992; 71: 18-26

16. Sugawara H, Sakurai K, Atsumi H, Nakada S, Tomoike H, Endoh M: Differential alterations of cardiotonic effects of EMD 57033 and &beta;-adrenoceptor agonists in volume-overload rabbit ventricular myocytes. J Card Fail 2000 (in press)

17. Gwathmey JK, Morgan JP: Altered calcium signaling in experimental pressure-overload hypertrophy in the ferret. Circ Res 1985; 57: 836-843

18. Mogan JP: Abnormal intracellular modulation of calcium as a major cause of cardiac contractile dysfunction. N Engl J Med 1985; 325: 625-632

10.1016/0022-2828(91)90049-R

20. Gwathmey JK, Copelas L, MacKinnon R, Schoen FJ, Feldman MD, Grossman W, et al: Abnormal intracellular calcium handling in myocardium from patients with end-stage heart failure. Circ Res 1987; 61: 70-76

21. Hasenfuss G, Reinecke H, Studer R, Meyer M, Pieske B, Holtz J, et al: Relation between myocardial function and expression of sarcoplasmic reticulum Ca<SUP>2+</SUP>-ATPase in failing and nonfailing human myocardium. Circ Res 1994; 75: 434-442

22. Mercadier JJ, Lompre AM, Duc P, Boheler KR, Fraysse JB, Wisnewsky C, et al: Altered sarcoplasmic reticulum Ca<SUP>2+</SUP>-ATPase gene expression in the human ventricle during end-stage heart failure. J Clin Invest 1990; 85: 305-309

23. Arai M, Alpert NR, MacLennan DH, Barton P, Periasamy M: Alterations in sarcoplasmic reticulum gene expression in human heart failure: A possible mechanism for alterations in systolic and diastolic properties of the failing myocardium. Circ Res 1993; 72: 463-469

24. Wankerl M, Schwartz K: Calcium transport proteins in the nonfailing and failing heart: Gene expression and function. J Mol Med 1995; 73: 487-496

25. Takahashi T, Allen PD, Izumo S: Expression of A-, B-, and C-type natriuretic peptide genes in failing and developing human ventricles: Correlation with expression of the Ca<SUP>2+</SUP>-ATPase gene. Circ Res 1992; 71: 9-17

10.1016/0022-2828(95)90059-4

10.1016/0014-5793(88)80303-X

1989, 86, 2966, 10.1073/pnas.86.8.2966

29. Matsui H, MacLennan DH, Alpert NR, Periasamy M: Sarcoplasmic reticulum gene expression, in pressure overload-induced cardiac hypertrophy in rabbit. Am J Physiol 1995; 268: C252-C258

30. Vatner DE, Sato N, Kiuchi K, Shannon RP, Vatner SF: Decrease in myocardial ryanodine receptors and altered excitation-contraction coupling early in the development of heart failure. Circulation 1994; 90: 1423-1430

10.1006/jmcc.1996.0327

32. Studer R, Reinecke H, Bilger J, Eschenhagen T, Bohm M, Hasenfuss G, et al: Gene expression of the cardiac Na<SUP>+</SUP>-Ca<SUP>2+</SUP> exchanger in end-stage human heart failure. Circ Res 1994; 75: 443-453

33. Kent RL, Rozich JD, McCollam PL, McDermott DE, Thacker UF, Menick DR, et al: Rapid expression of the Na<SUP>+</SUP>/Ca<SUP>2+</SUP> exchanger in response to cardiac pressure overload. Am J Physiol 1993; 265: H1024-H1029

34. Dixon IM, Hata T, Dhalla NS: Sarcolemmal calcium transport in congestive heart failure due to myocardial infarction in rats. Am J Physiol 1992; 262: H1387-H1394

Kranias EG, Schwartz A, Jungmann RA, 1982, 709, 28

36. Kadambi VJ, Ponniah S, Harrer JM, Hoit BD, Dorn GW, Walsh RA, et al: Cardiac specific overexpression of phospholamban alters calcium kinetics and resultant cardiomyocyte mechanics in transgenic mice. J Clin Invest 1996; 97: 533-539